<DOC>
	<DOCNO>NCT00148408</DOCNO>
	<brief_summary>The purpose research study investigate way educational approach presentation drug may affect response montelukast placebo ( inactive medication ) subject asthma .</brief_summary>
	<brief_title>Trial Asthma Patient Education ( TAPE )</brief_title>
	<detailed_description>This study effect education drug presentation efficacy montelukast placebo asthma . This trial answer follow question : 1 ) Is true placebo response asthma due non-specific factor ? 2 ) Can placebo effect asthma augment intervention increase expectancy benefit ? 3 ) Can interventions increase expectancy augment effect active treatment ? 4 ) Are placebo effect additive interactive treatment effect ?</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>age 15 old physician diagnose asthma regular use prescribe asthma medication precede year postbronchodilator FEV1 least 75 % predicted inadequate asthma control precede two month current past smoking ( great 10 packyears ) serious asthma exacerbation within previous three month regular use oral corticosteroid history respiratory failure due asthma current use montelukast history adverse reaction montelukast concomitant interfere medical condition participation another clinical trial inability unwillingness perform study procedure pregnancy , lack effective contraception ( appropriate ) , lactation</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Placebo</keyword>
	<keyword>Education</keyword>
</DOC>